Search Results (1,172)

Smart nanocarriers are being increasingly explored to improve the performance selectivity of cancer chemotherapy. Here, two pH-responsive magnetic nanocarriers were developed using quaternary chitosan (HTCC) functionalized with 3-(triethoxysilyl)propyl isocyanate- ICPTES (MNP-HTCC1) or 3-(glycidyloxypropyl)trimethoxysilane-GPTMS (MNP-HTCC2) to form hybrid silica shells on Fe₃O₄ cores. The resulting core–shell nanoparticles (14.5 and 12.5 nm) displayed highly positive zeta potentials (+45.4 to +27.1 mV, pH 4.2–9.5), confirming successful HTCC incorporation and strong colloidal stability. Both nanocarriers achieved high doxorubicin (DOX) loading at pH 9.5, reaching 90% efficiency and a capacity of 154 µg DOX per mg. DOX release was pH-dependent, with faster release under acidic conditions relevant to tumor and endo-lysosomal environments. At pH 4.2, MNP-HTCC1 released 90% of DOX over 72 h, while MNP-HTCC2 released 79%. Release at pH 5.0 was intermediate (67–72%), and moderate at physiological pH (43–55%). All formulations showed an initial burst followed by sustained release. Kinetic modelling (Weibull) indicated a diffusion-controlled mechanism consistent with Fickian transport through the HTCC–silica matrix. Cytotoxicity assays using MCF-7 breast cancer cells revealed greater cytotoxicity for DOX-loaded nanocarriers compared with free DOX, with MNP-HTCC1 showing the strongest effect. Overall, these HTCC-based magnetic nanocarriers offer efficient loading, controlled pH-triggered DOX release, and enhanced therapeutic performance. Full article

Nanoparticle-mediated photothermal conversion exploits the unique light-to-heat transduction properties of engineered nanomaterials to address challenges in energy, water, and healthcare. This review first examines fundamental mechanisms—localized surface plasmon resonance (LSPR) in plasmonic metals and broadband interband transitions in semiconductors—demonstrating how tailored nanoparticle compositions can achieve >96% absorption across 250–2500 nm and photothermal efficiencies exceeding 98% under one-sun illumination (1000 W·m⁻², AM 1.5G). Next, we highlight advances in solar steam generation and desalination: floating photothermal receivers on carbonized wood or hydrogels reach >95% efficiency in solar-to-vapor conversion and >2 kg·m⁻²·h⁻¹ evaporation rates; three-dimensional architectures recapture diffuse flux and ambient heat; and full-spectrum nanofluids (LaB₆, Au colloids) extend photothermal harvesting into portable, scalable designs. We then survey photothermal-enhanced thermal energy storage: metal-oxide–paraffin composites, core–shell phase-change material (PCM) nanocapsules, and MXene– polyethylene glycol—PEG—aerogels deliver >85% solar charging efficiencies, reduce supercooling, and improve thermal conductivity. In biomedicine, gold nanoshells, nanorods, and transition-metal dichalcogenide (TMDC) nanosheets enable deep-tissue photothermal therapy (PTT) with imaging guidance, achieving >94% tumor ablation in preclinical and pilot clinical studies. Multifunctional constructs combine PTT with chemotherapy, immunotherapy, or gene regulation, yielding synergistic tumor eradication and durable immune responses. Finally, we explore emerging opto-thermal nanobiosystems—light-triggered gene silencing in microalgae and poly(N-isopropylacrylamide) (PNIPAM)–gold nanoparticle (AuNP) membranes for microfluidic photothermal filtration and control—demonstrating how nanoscale heating enables remote, reversible biological and fluidic functions. We conclude by discussing challenges in scalable nanoparticle synthesis, stability, and integration, and outline future directions: multicomponent high-entropy alloys, modular photothermal–PCM devices, and opto-thermal control in synthetic biology. These interdisciplinary innovations promise sustainable solutions for global energy, water, and healthcare demands. Full article

Seawater has attracted increasing attention as a promising resource for hydrogen production via electrolysis. However, multivalent ions present in seawater can reduce the efficiency of direct seawater electrolysis (DSWE) by forming inorganic precipitates at the cathode. Bipolar membranes (BPMs) can mitigate precipitate formation by regulating local pH, thereby enhancing DSWE efficiency. Accordingly, this study focuses on the fabrication of a high-performance BPM for DSWE applications. The water-splitting performance of BPMs is strongly dependent on the properties of the catalyst at the bipolar junction. Herein, iron oxide (Fe₃O₄) nanoparticles were coated with cross-linked chitosan to improve solvent dispersibility and catalytic activity. The resulting core–shell catalyst exhibited excellent dispersibility, facilitating uniform incorporation into the BPM. Water-splitting flux measurements identified an optimal catalyst loading of approximately 3 μg cm⁻². The BPM containing Fe₃O₄–chitosan nanoparticles achieved a water-splitting flux of 26.2 μmol cm⁻² min⁻¹, which is 18.6% higher than that of a commercial BPM (BP-1E, Astom Corp., Tokyo, Japan). DSWE tests using artificial seawater as the catholyte and NaOH as the anolyte demonstrated lower cell voltage and stable catholyte acidification over 100 h compared to the commercial membrane. Full article

Background/Objectives: Research on noble metal nanoparticles (NPs) has increased over the past three decades, with advancements in synthesis techniques refining their physicochemical characteristics, including size, shape, and surface chemistry. Bimetallic NPs (BNPs) offer synergistic properties contributed by both metals. Gold (Au) and palladium (Pd) NPs possess low toxicity, high biocompatibility and loading, ease of synthesis and surface modification. Doxorubicin (DOX) and 5-fluorouracil (5-FU) are potent chemotherapeutic drugs but are rapidly metabolised in the body, producing severe side effects, limiting their use. Hence, innovative strategies to mitigate this is needed. Methods: In this study, AuPd NPs in a core-shell formation were chemically synthesized. The AuPd NPs were conjugated to 5-FU and DOX-encapsulated CS complexes and decorated with the targeting moiety transferrin (Tf). Results: Transmission electron microscopy and nanoparticle tracking analysis confirmed that the BNPs were spherical, with an average size of 73.4 nm. Functionalized BNPs were able to encapsulate more than 70% of 5-FU and DOX, resulting in a controlled drug release profile at pH 4.2. Cytotoxicity levels in human cancer cells, HeLa (cervical carcinoma) and MCF-7 (breast adenocarcinoma), as well as in non-cancer HEK293 (embryonic kidney) cells, revealed that the Tf-targeted nanocomplexes were HeLa cell-specific, with no significant cytotoxicity in the HEK293 cells. Tf-mediated cellular uptake was confirmed by receptor competition studies in the HeLa cells. Apoptosis and oxidative stress analysis confirmed cell death by apoptosis, consistent with the action of 5-FU and DOX. Conclusions: This study highlighted the potential of this BNP-nanocomplex as a suitable vehicle for drug delivery. Full article

Background/Objectives: The growing threat posed by antimicrobial resistance to worldwide public health highlights the urgent need not only for new anti-infective candidates, but also for innovative formulation strategies capable of mediating effective delivery of anti-infective compounds. The current study, therefore, aimed to demonstrate the feasibility of formulating lipid-polymer hybrid nanoparticles (LPHNPs) with dual loading of both core and shell compartments for combination anti-infective delivery. Methods: LPHNPs containing the antibiotic cefotaxime within a chitosan polymer core and the novel antimicrobial peptide RN7IN6 within a bacteria-mimicking lipid shell were produced by microfluidic mixing, and optimized with respect to parameters including total flow rate, flow rate ratio, and lipid concentration. Minimum inhibitory concentrations of cefotaxime and RN7IN6 co-incorporated in LPHNPs were assessed as a preliminary indicator of antibacterial efficacy. Results: Uniformly nanosized LPHNPs were produced, with maximized loading of cefotaxime and RN7IN6 within particle cores and shells, respectively. Empty LPHNPs showed an appreciable antibacterial activity, particularly against the Gram-negative bacterium Escherichia coli, while RN7IN6 was indicated to enhance cefotaxime activity against E. coli when both actives were incorporated in LPHNPs. Conclusions: The current findings clearly demonstrate the feasibility of formulating LPHNPs for core-shell co-encapsulation and delivery of anti-infectives. The promising antibacterial efficacy of co-loaded LPHNPs warrants further in-depth investigation to determine the extent of co-loaded LPHNP applications as combination anti-infective delivery platforms. Full article

Magnetite (Fe₃O₄) nanoparticles are biocompatible, non-toxic, and easily functionalized. Coating them with mesoporous silica (mSiO₂) offers high surface area, pore volume, and tunable surface chemistry for drug loading. In this study, Fe₃O₄ magnetic nanoparticles were synthesized and coated with mSiO₂ shells enriched with calcium ions (Ca²⁺), aiming to enhance bioactivity for bone regeneration and tissue engineering. Different synthesis routes were tested to optimize shell formation Their characterization confirmed the presence of a crystalline Fe₃O₄ core with partial conversion to maghemite (Fe₂O₃) post-coating. The silica shell was mostly amorphous and the optimized samples exhibited mesoporous structure (type IVb). Calcium incorporation slightly altered the magnetic properties without significantly affecting core crystallinity or particle size (11.68–13.56 nm). VSM analysis displayed symmetric hysteresis loops and decreased saturation magnetization after coating and Ca²⁺ addition. TEM showed spherical morphology with some agglomeration. MTT assays confirmed overall non-toxicity, except for mild cytotoxicity at high concentrations in the Ca²⁺-enriched sample synthesized by a modified Stöber method. Their capacity to induce human periodontal ligament cell osteogenic differentiation, further supports the potential of Fe₃O₄/mSiO₂/Ca²⁺ core–shell nanoparticles as promising candidates for bone-related biomedical applications due to their favorable magnetic, structural, and biological properties. Full article

Lipid-based nanomedicines are already widely used in antitumor therapy and gene delivery. However, their complex structural features demand advanced mesoscopic structural characterization tools for effective research and development (R&D) and quality control. Synchrotron small-angle X-ray scattering (SAXS) is a powerful, non-invasive technique for probing nanoscale membrane organizations, monitoring in situ dynamic membrane assembly, and exploring the interactions of components in lipid-based drug delivery systems, including liposomes, lipoplexes, lipid nanoparticles (LNPs), and lyotropic liquid crystals (LLCs). Recent advances in high-flux synchrotron facilities, high-frequency detectors, and automated SAXS data processing pipelines permit a detailed structural characterization of lamellarity, bilayer spacing, internal phases, core–shell morphology, as well as “pump-probe” dynamic process studies for lipid nanomedicines. Though major challenges remain in sample polydispersity and model fitting, the advances in time-resolved synchrotron SAXS, high-throughput automation, and artificial intelligence (AI)-assisted modeling are rapidly reducing this barrier. This review summarizes SAXS methodology and introduces representative case studies in the field of lipid nanomedicines. The performance of BioSAXS beamline BL19U2 in the Shanghai synchrotron radiation facility (SSRF) and prospects of AI-guided drug screening at BL19U2 are highlighted to advance intelligent R&D and quality control for lipid nanomedicines. Full article

Background: Nanomedicine has demonstrated great potential to improve drug delivery across various diseases. However, accurately monitoring the real-time trafficking of organic nanoparticles (NPs) within biological systems remains a significant challenge. Current detection methods rely heavily on fluorescence, while high-resolution, label-free imaging is often precluded by the limited optical contrast of organic materials, limiting a comprehensive understanding of NP fate. Metallic doping allows simultaneous detection of carriers using multiple imaging and analysis techniques. This study presents a novel approach to prepare gold-doped hybrid NPs compatible with multimodal imaging, thus facilitating multimodal tracking. Methods: Gold-doped NPs were successfully synthesized via nanoprecipitation, yielding stable, monodisperse carriers with optimal size, confirmed by Dynamic Light Scattering and Nanoparticle Tracking Analysis. UV/Vis spectroscopy confirmed effective gold-doping, with doping efficiency of approximately 50%. Transmission Electron Microscopy (TEM) showed gold NP accumulation throughout the polymer core and near the lipid shell. Results: Although gold doping resulted in a slight increase in NP size and zeta potential, no effects on cytocompatibility or cellular uptake by glioblastoma and microglia cells were observed. Furthermore, the optical properties (i.e., the refractive index and the UV spectrum) of the NPs were successfully modified to enable tracking across complementary imaging modalities. Real-time, label-free visualization of NP accumulation in the cytoplasm of U87 cells was achieved via holotomography by exploiting the enhanced refractive index after gold-doping. This observation was confirmed through correlation with fluorescence confocal microscopy, using fluorescently labelled gold-doped NPs. Furthermore, the high electron density of the gold tracer facilitated the precise localization of NPs within intracellular compartments via TEM, bypassing the inherently low contrast of organic NPs. Conclusions: These findings validated the gold-doped NPs as versatile nanoplatforms for multimodal imaging, showcasing their potential for non-invasive, high-resolution tracking and more accurate quantification of intracellular accumulation using diverse analytical techniques. Full article

Metal nanoparticles (NPs) with enzyme-mimicking activities, known as nanozymes, are being actively explored for biomedical and analytical applications. Enhancing their catalytic activity and metal utilization efficiency is crucial for advancing these technologies. Here, we report an aqueous-phase, room-temperature synthesis of tetra-metallic Au@Ag-Pd-Pt NPs that exhibit superior peroxidase-like activity compared to their mono-, bi-, and trimetallic counterparts. The synthesis involves a sequential, seed-mediated approach comprising the formation of Au NP seeds, the overgrowth of a Ag shell, and the galvanic replacement of Ag with Pd and Pt ions. We systematically investigated the effects of the Au core diameter (15, 40, 55 nm), Ag precursor concentration (50–400 µM), and the Pd-to-Pt ratio on the optical and catalytic properties. By changing the particle composition, we were able to tune the absorbance maximum from 520 nm to 650 nm while maintaining high extinction coefficients (10⁹–10¹⁰ M⁻¹cm⁻¹) comparable to that of the initial Au nanoparticles. Mapping of chemical element distributions in the nanoscale range confirmed a core–shell–shell architecture with surface-enriched Pd and Pt. This structure ensures the surface-exposed localization of catalytically active atoms, yielding a more than 10-fold improvement in specific peroxidase-like activity while utilizing up to two orders of magnitude less Pt and Pd than bimetallic particles. The synthesized NPs thus combine high catalytic activity with tunable optical properties, making them promising multifunctional labels for biosensing. Full article

Composite materials based on low-density polyethylene (LDPE) embedded with iron-manganese nanoparticles with compositions Fe_0.9Mn_0.1 and Fe_0.8Mn_0.2 were prepared and investigated. The newly created composites were characterized using transmission electron microscopy (TEM), X-ray diffraction (XRD), X-ray absorption near-edge structure (XANES), extended X-ray absorption fine structure (EXAFS), and Mössbauer spectroscopy. The composition, electronic, and atomic structure of the nanoparticles were established. The study confirms that the nanoparticles possess a ‘core-shell’ structure, the nature of which depends on the manganese content. The nanoparticles of Fe_0.8Mn_0.2 in LDPE exhibit a three-layered structure: a metallic α-Fe core is coated with an intermediate oxidized layer structurally close to Fe₂O₃, while the outermost shell consists of manganese oxide (Mn₂O₃). In contrast, nanoparticles with lower Mn content Fe_0.9Mn_0.1 show a predominantly fully oxidized structure. This structural evolution is consistent with thermodynamic principles, where manganese, having a higher oxide formation enthalpy, migrates to the surface. The core–shell architecture is promising for applications requiring stable magnetic components or tailored catalytic interfaces within a polymer matrix. Full article

Background: Copper nanoparticles (CuNPs) are promising antibacterial agents, but instability and heterogeneity in ‘green’ routes limit translation. Methods: We developed a one-step synthesis in which pre-polymerized polycatechin acts as both reductant and capping agent to form copper–polycatechin core–shell nanoparticles (Cu@polycat). Physicochemical properties (TEM/DLS/XRD/FTIR/ζ), colloidal stability (pH, salt, serum), ion release, and antibacterial activity against planktonic and biofilm E. coli/S. aureus were evaluated. Results: Cu@polycat featured a ~21.5 nm metallic core and ~45 nm hydrodynamic diameter (shell ≈ 12 nm, estimated from TEM–DLS) with ζ ≈ −34 mV, conferring high stability across physiological conditions. Cu@polycat outperformed uncoated CuNPs, displaying 8-fold lower MICs and rapid bactericidal kinetics (>5-log10 in 6–8 h). Synergy between the copper core and polycatechin corona was confirmed (FICI ≈ 0.08). Cu@polycat inhibited biofilm formation by >80% and reduced viable counts in 24 h mature biofilms by ≥3-log10, whereas ampicillin was ineffective under the same biofilm conditions. Conclusions: A polycatechin-based green route furnishes a stable, synergistic nano-antibacterial platform with potent anti-biofilm activity, supporting development for wound-care and anti-fouling device coatings. Full article

Encapsulins are microbial protein nanocompartments that spatially organize and sequester specific biochemical processes, including iron storage. While their protein shells have been extensively characterized, the composition and structure of their mineral cores remain less understood. Here, we use bright field transmission electron microscopy (BF TEM), high-angle annular dark-field scanning TEM (HAADF STEM), energy-dispersive X-ray (EDX), and electron energy-loss spectroscopy (EELS) in STEM to characterize the iron-containing mineral granules within the Myxococcus xanthus encapsulin system at near atomic resolution. We find that the internal nanoparticles are smaller (~2 nm) and more numerous (up to ~2200 per encapsulin) than previously reported. These nanoparticles are typically amorphous and have a composition consistent with FePO₄ (measured Fe:P ratio of ≈1:1.2). Each encapsulin contains on average ~8500 iron atoms, corresponding to a volumetric density of 2.1 atoms/nm³. Phosphorus incorporation inhibits crystallization, whereas growth in phosphorus-free media leads to the formation of nano-crystalline goethite [α-FeO(OH)]. Full article

Designing metal–semiconductor-based core–shell nanostructures with strong interactions is emerging as a unique component for chemiresistor applications. Here, we have developed an effective hydrogen (H₂) gas sensor based on Au-In₂O₃ core–shell nanostructures, which were synthesized through a short-time microwave hydrothermal process. At an optimal temperature of 375 °C, the device based on Au-In₂O₃ displays a high sensitivity of ~42, which is five times greater than that of the In₂O₃ toward 100 ppm of H₂ gas. Moreover, the Au-In₂O₃ sensor showed higher selectivity toward H₂ gas and stability over a long period. The excellent H₂ gas-sensing performance of Au-In₂O₃ core–shell nanoparticles can be credited to the sensitization and Au catalytic effect core, and their strong interaction with the In₂O₃ component. Our work not only accounts for a facile synthesis approach for Au-In₂O₃ core–shell nanoparticles by synergistic properties of Schottky heterojunctions, but also offers a new insight into how strong metal–semiconductor interactions (SMSIs) play a dynamic role in developing high-performance gas-sensing devices. Full article

This study presents a sustainable and efficient method for fabricating core–shell structured palladium catalysts using a bacterial template and sol–gel synthesis. This synthesis aligns with green chemistry principles by minimizing waste and enhancing resource efficiency. Our results demonstrate that the bacterial template effectively stabilizes Pd nanoparticles (NPs), preventing significant agglomeration during synthesis and subsequent calcination under different atmospheres and final temperatures. The catalyst samples were characterized by SEM, TEM, XRD, and TGA. The 1 wt% Pd/R@SiO₂ catalyst exhibited high activity in the Suzuki–Miyaura cross-coupling reaction, achieving competitive yields. Furthermore, the catalyst demonstrated a stable performance over five consecutive cycles. This work underscores the potential of biotemplated synthesis as a versatile and eco-friendly platform for producing high-performance, tunable catalysts. Full article

Lipid-polymer hybrid nanoparticles (LPHNPs) are the next-generation nanocarriers that integrate the mechanical strength and sustained-release capacity of polymeric cores with the biocompatibility and high drug-loading efficiency of lipid shells. Various design strategies and architectures that enhance encapsulation efficiency, stability, and targeted delivery of diverse therapeutic agents are reviewed. Commonly employed polymers, lipids, and surfactants that enable controlled drug release and enhanced pharmacokinetic performance are summarized in tabular form, while fabrication methods such as single-step, emulsification-solvent evaporation, and microfluidic techniques are discussed for their scalability and reproducibility. The therapeutic potential of LPHNPs in delivering poorly soluble drugs, phytochemicals, and genetic materials achieving synergistic therapeutic outcomes in oncological applications is comprehensively highlighted. The manuscript also includes details on ligand-based functionalization and the integration of imaging and stimuli-responsive elements to enhance targeted delivery and develop multifunctional theranostic LPHNPs systems. Furthermore, non-oncologic applications of LPHNPs in ocular, topical, and oral delivery are discussed, emphasizing their potential in treating inflammatory, infectious, and autoimmune disorders with sustained release and enhanced therapeutic efficacy. Recent patents focusing on improved biocompatibility, dual-drug encapsulation, and mRNA delivery are summarized. However, challenges such as large-scale production, reproducibility, safety, and regulatory standardization must be addressed through quality by design approaches and advanced manufacturing technologies to fully realize the clinical and commercial potential of next-generation LPHNPs. Full article